$26.07
-1.38-5.03%
Last update: Nov 5, 4:00 PM
Stoke Therapeutics Inc
STOKNASDAQ
The average analyst price target for Stoke Therapeutics is $41.15, 57.8% above the current price. Of 13 analysts, 13 rate it Buy. Targets range from $24 to $60. The latest change came on Aug 4, 2026, when Wedbush raised its price target on Stoke Therapeutics from $38 to $40 and kept an Outperform rating.
Price Target Range — 12 Quarters
Analyst Consensus — 13 Analysts
Rating Trend — Last 9 Months
